Eletriptan |
Relpax |
Image:Eletriptan.png Eletriptan Systematic (IUPAC) name 3-[(1-methylpyrrolidin-2-yl) methyl]-5- (2-phenylsulfonylethyl)- 1H-indole Identifiers CAS number 143322-58-1 ATC code N02CC06 PubChem 77993 DrugBank APRD00945 Chemical data Formula C22H26N2O2S Mol. weight 382.52 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life ? Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status Routes ? ...
Wikipedia - [full article]
Eletriptan Clinical Trials
- Efficacy of Combination Product (Sumatriptan Succinate/Naproxen Sodium) in Eletriptan Non-Responders.
ClinicalTrials.gov Identifier: NCT00382993 - Recruiting
Migraine
- Efficacy of Combination Product (Sumatriptan Succinate/Naproxen Sodium) in Eletriptan Non-Responders.
ClinicalTrials.gov Identifier: NCT00383162 - Recruiting
Migraine
- Prospective Survey of Menstrual Migraine & Prevention With Eletriptan
ClinicalTrials.gov Identifier: NCT00259649 - Recruiting
Migraine
- A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine
ClinicalTrials.gov Identifier: NCT00174395 - Completed
Migraine
Resources
- Eletriptan (Drug Digest)
- Relpax (Drug Digest)

Not Signed In -


